Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

Photo of Jon C. Ogg
By Jon C. Ogg Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

It is the first full trading week of 2014, and investors are trying to decide how to position their portfolios for the year. Wall Street brokerage firms are making their 2014 predictions almost daily now, and the stock market is effectively at all-time highs. 24/7 Wall St. reviews many fresh research calls each and every morning on the hunt for new ideas, and we have broken out the negative analyst calls today. These are this Monday’s top analyst downgrades and cautious research notes from Wall Street.

Apple Inc. (NASDAQ: AAPL) was downgraded to Sell from an already cautious Hold rating at a boutique firm called Standpoint Research. The reason for this downgrade seems to be based more on moral reasons rather than fundamental ones, although these can overlap if sentiment and media move against a company. Apple shares were down 2% on Friday, and shares were indicated marginally lower on Monday after this call.

Twitter Inc. (NYSE: TWTR) has taken yet another downgrade, this one coming from Morgan Stanley. The firm dropped the micro-blogging leader down to Underweight from an already cautious Equal Weight. Effectively, this is a Sell rating. The price target is down at $33 per share, versus a $69.00 closing bell price. Shares were indicated down another 3% on Monday. Maybe having a valuation at 60 times revenues is still just too much.

First Solar Inc. (NASDAQ: FSLR) was downgraded to Sell from Buy at Goldman Sachs, and shares were indicated down almost 5%, after the firm went to favoring the service side of the solar equation rather than the panel side.

Other key analyst downgrades were seen in the following stocks:

AFLAC Inc. (NYSE: AFL) was downgraded to Neutral from Outperform at Credit Suisse.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) was downgraded to Neutral from Buy at Goldman Sachs.

ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA) was downgraded to Sell from Neutral at Citigroup.

Arris Enterprises Inc. (NASDAQ: ARRS) was downgraded to Equal Weight from Overweight at Barclays.

Celgene Corp. (NASDAQ: CELG) was downgraded to Sell from Neutral at Goldman Sachs.

eBay Inc. (NASDAQ: EBAY) was downgraded to Equal Weight from Overweight at Morgan Stanley.

Sanofi (NYSE: SNY) was downgraded to Neutral from Overweight at J.P. Morgan.

Wendy’s Co. (NASDAQ: WEN) was downgraded to Neutral from Buy at Janney Capital Markets.

WEX Inc. (NYSE: WEX) was downgraded to Underperform from Neutral based on an unfavorable risk/reward profile with a $90 price target (versus a $97.10 close) at Sterne Agee.

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. a673b.bigscoots-temp.com.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618